Great Point Partners as of Dec. 31, 2017
Portfolio Holdings for Great Point Partners
Great Point Partners holds 38 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Zogenix | 7.7 | $45M | 1.1M | 40.05 | |
| Arena Pharmaceuticals | 6.8 | $40M | 1.2M | 33.97 | |
| Global Blood Therapeutics In | 6.7 | $40M | 1.0M | 39.35 | |
| Kura Oncology (KURA) | 5.7 | $34M | 2.2M | 15.30 | |
| Sage Therapeutics (SAGE) | 5.6 | $33M | 200k | 164.71 | |
| Neurocrine Biosciences (NBIX) | 5.3 | $31M | 400k | 77.59 | |
| Rigel Pharmaceuticals (RIGL) | 5.2 | $31M | 7.9M | 3.88 | |
| Foamix Pharmaceuticals | 4.9 | $29M | 4.8M | 6.01 | |
| BioCryst Pharmaceuticals (BCRX) | 4.0 | $23M | 4.8M | 4.91 | |
| Aimmune Therapeutics | 3.7 | $22M | 574k | 37.82 | |
| Spark Therapeutics | 3.6 | $21M | 411k | 51.42 | |
| Ptc Therapeutics I (PTCT) | 3.1 | $18M | 1.1M | 16.68 | |
| Novocure Ltd ord (NVCR) | 3.0 | $18M | 879k | 20.20 | |
| Concert Pharmaceuticals I equity | 3.0 | $17M | 670k | 25.87 | |
| Newlink Genetics Corporation | 2.8 | $16M | 2.0M | 8.11 | |
| Iovance Biotherapeutics (IOVA) | 2.7 | $16M | 2.0M | 8.00 | |
| Axovant Sciences | 2.6 | $15M | 2.9M | 5.27 | |
| Catalyst Pharmaceutical Partners (CPRX) | 2.5 | $15M | 3.8M | 3.91 | |
| Biohaven Pharmaceutical Holding | 2.3 | $14M | 500k | 26.98 | |
| Savara (SVRA) | 2.2 | $13M | 870k | 14.84 | |
| Vanda Pharmaceuticals (VNDA) | 2.1 | $12M | 798k | 15.20 | |
| Wave Life Sciences (WVE) | 2.0 | $12M | 331k | 35.10 | |
| Revance Therapeutics (RVNC) | 1.8 | $11M | 300k | 35.75 | |
| Gw Pharmaceuticals Plc ads | 1.7 | $9.9M | 75k | 132.01 | |
| Dbv Technologies S A (DBVT) | 1.3 | $7.7M | 313k | 24.60 | |
| Acceleron Pharma | 1.2 | $7.3M | 173k | 42.44 | |
| Incyte Corporation (INCY) | 1.1 | $6.7M | 70k | 94.71 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.9 | $5.4M | 800k | 6.80 | |
| Acorda Therapeutics | 0.7 | $4.3M | 200k | 21.45 | |
| Corbus Pharmaceuticals Hldgs | 0.7 | $4.3M | 600k | 7.10 | |
| Amarin Corporation (AMRN) | 0.7 | $4.2M | 1.1M | 4.01 | |
| Jounce Therapeutics | 0.6 | $3.7M | 293k | 12.75 | |
| Kadmon Hldgs | 0.5 | $3.0M | 840k | 3.62 | |
| Myovant Sciences | 0.3 | $2.0M | 161k | 12.64 | |
| Selecta Biosciences (RNAC) | 0.3 | $1.7M | 178k | 9.81 | |
| Dermira | 0.2 | $1.2M | 44k | 27.82 | |
| Connecture | 0.1 | $660k | 4.1M | 0.16 | |
| Streamline Health Solutions (STRM) | 0.0 | $220k | 130k | 1.69 |
